文献速递流行病学与生物统计临床试验与 GCP

未调查性消化不良管理策略有效性的系统综述与网络荟萃分析

Effectiveness of management strategies for uninvestigated dyspepsia: systematic review and network meta-analysis.
PubMed 文献 · BMJ · 2019-12-11

该系统综述与网络荟萃分析纳入15项随机对照试验共6162例成人未调查性消化不良患者,比较五种管理策略。幽门螺杆菌「检测与治疗」策略排名第一(症状持续RR 0.89,95%CI 0.78-1.02),但与立即内镜表现相似且未显著优于其他策略;该策略内镜检查率显著低于立即内镜。

要点

  • 「检测与治疗」排名第一,但与立即内镜效果相似,且未显著优于其他策略。
  • 「检测与治疗」内镜检查率显著低于立即内镜(RR 0.23,95%CI 0.17-0.31)。
  • 立即内镜的管理不满意率显著低于「检测与治疗」和经验性抑酸。

核心结论

  • 「检测与治疗」策略排名第一,但与立即内镜表现相似,且未显著优于任何其他策略。
  • 「检测与治疗」较除症状导向管理外的所有策略均减少内镜检查。
  • 参与者更倾向于立即内镜作为其症状的管理策略。

研究设计与样本

  • 系统综述与网络荟萃分析,检索Medline、Embase、Cochrane CENTRAL及clinicaltrials.gov至2019年9月,无语言限制。
  • 纳入15项随机对照试验,共6162例成人(年龄≥18岁)未调查性消化不良患者。
  • 纳入试验报告最终随访(≥12个月)时症状状态的双分类评估。

主要发现

  • 「检测与治疗」排名第一(症状持续RR 0.89,95%CI 0.78-1.02,P score 0.79),立即内镜排名第二但表现相似(RR 0.90,95%CI 0.80-1.02,P score 0.71)。
  • 「检测与治疗」组接受内镜检查的可能性显著低于立即内镜(RR 0.23,95%CI 0.17-0.31,P score 0.98)。
  • 立即内镜的管理不满意率显著低于「检测与治疗」(RR 0.67,95%CI 0.46-0.98,P score 0.95)和经验性抑酸(RR 0.58,95%CI 0.37-0.91)。
  • 所有试验中上消化道癌症发生率均低。

临床怎么用

  • 「检测与治疗」可作为未调查性消化不良的管理策略之一,有助于减少内镜检查。
  • 需考虑参与者对立即内镜的偏好及内镜在管理满意度上的优势。

局限性

  • 个体试验偏倚风险高,因实用性试验设计无法实施盲法。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the effectiveness of management strategies for uninvestigated dyspepsia. DESIGN: Systematic review and network meta-analysis. DATA SOURCES: Medline, Embase, Embase Classic, the Cochrane Central Register of Controlled Trials, and clinicaltrials.gov from inception to September 2019, with no language restrictions. Conference proceedings between 2001 and 2019. ELIGIBILITY CRITERIA FOR SELECTING STUDIES: Randomised controlled trials that assessed the effectiveness of management strategies for uninvestigated dyspepsia in adult participants (age ≥18 years). Strategies of interest were prompt endoscopy; test for Helicobacter pylori and perform endoscopy in participants who test positive; test for H pylori and eradication treatment in those who test positive ("test and treat"); empirical acid suppression; or symptom based management. Trials reported dichotomous assessment of symptom status at final follow-up (≥12 months). RESULTS: The review identified 15 eligible randomised controlled trials that comprised 6162 adult participants. Data were pooled using a random effects model. Strategies were ranked according to P score, which is the mean extent of certainty that one management strategy is better than another, averaged over all competing strategies. "Test and treat" ranked first (relative risk of remaining symptomatic 0.89, 95% confidence interval 0.78 to 1.02, P score 0.79) and prompt endoscopy ranked second, but performed similarly (0.90, 0.80 to 1.02, P score 0.71). However, no strategy was significantly less effective than "test and treat." Participants assigned to "test and treat" were significantly less likely to receive endoscopy (relative risk v prompt endoscopy 0.23, 95% confidence interval 0.17 to 0.31, P score 0.98) than all other strategies, except symptom based management (relative risk v symptom based management 0.60, 0.30 to 1.18). Dissatisfaction with management was significantly lower with prompt endoscopy (P score 0.95) than with "test and treat" (relative risk v "test and treat" 0.67, 0.46 to 0.98), and empirical acid suppression (relative risk v empirical acid suppression 0.58, 0.37 to 0.91). Upper gastrointestinal cancer rates were low in all trials. Results remained stable in sensitivity analyses, with minimal inconsistencies between direct and indirect results. Risk of bias of individual trials was high; blinding was not possible because of the pragmatic trial design. CONCLUSIONS: "Test and treat" was ranked first, although it performed similarly to prompt endoscopy and was not superior to any of the other strategies. "Test and treat" led to fewer endoscopies than all other approaches, except symptom based management. However, participants showed a preference for prompt endoscopy as a management strategy for their symptoms. SYSTEMATIC REVIEW REGISTRATION: PROSPERO registration number CRD42019132528.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Eusebi LH, Black CJ, Howden CW, et al. Effectiveness of management strategies for uninvestigated dyspepsia: systematic review and network meta-analysis. BMJ. 2019. PMID: 31826881. doi:10.1136/bmj.l6483

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。